Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are classified on the basis of their activation by different agonists. The agonists kainate and a-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid define a class of glutamate receptors termed kainate receptors. We have isolated and sequenced a human glutamate receptor (GluHI) cDNA and determined the chromosomal localization of its gene. The DNA sequence of GIuHI would encode a 907-amino acid protein that has a 97% identity to one of the rodent kainate receptor subunits. Many of the changes between the predicted amino acid sequence of GluHI and the most similar rodent kainate receptor (GIuRI) occur in a region of the protein encoded in rodents by an alternatively spliced exon. The extreme conservation between the human and rat kainate receptor subunits suggests that a similar gene family will encode human kainate receptors. The GIuHI mRNA is widely expressed in human brain. The human gene encoding the GluHI subunit is located at 5q33. While the GIuHI gene is not located near a chromosomal region associated with any human neurogenetic disorders, the homologous region on mouse chromosome 11 contains the sites of five neurologic mutations.
Glutamate receptors are the predominant excitatory neurotransmitter receptor in the mammalian brain and are activated in a variety of normal neurophysiological processes (1, 2) . The classification of glutamate receptors has been based on their activation by different pharmacological agonists. Glutamate receptors have therefore been named according to their respective agonists, the N-methyl-D-aspartate (NMDA), quisqualic acid (QUIS), kainate (KA), and 2-amino-4-phosphonobutyrate (AP4) receptors (1) . Quisqualate receptors are also activated by the more selective agonist a-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid (AMPA).
The molecular cloning of cDNA for a rodent glutamate receptor (GIuRI) has led to significant advances in our understanding of KA-and AMPA-gated glutamate receptors (3) . Four additional types of KA receptor subunit cDNAs have been isolated from rat with various degrees of nucleotide and amino acid sequence identity to GluRI (3) (4) (5) (6) (7) . Comparison of these sequences suggests that glutamate receptors sensitive to KA and AMPA are encoded by a family ofclosely related genes. The coexpression of different complementary RNA (cRNA) transcripts derived from these cDNAs in Xenopus oocytes has shown that (i) the respective protein products can interact to form heteromeric receptors; (ii) the agonists KA and AMPA can activate the same receptor or receptor subunit combinations; and (ifi) different combinations of receptor subunits display distinct electrical properties (3) (4) (5) (6) (7) . The extended family of related KA/AMPA receptor genes in rats suggests that, if these genes are conserved, multiple receptor subunit genes will also be used to generate diversity in human KA receptors. Human glutamate receptors are of medical interest because of their postulated role in the mediation of excitation-induced neuronal cell death, particularly in stroke and inherited neurodegenerative disorders (8, 9) . To determine ifglutamate receptors are involved in any inherited neurodegenerative disorders will require the molecular cloning of human glutamate receptor genes and the determination of any linkage of these genes to inherited neurodegenerative disorders. To begin this analysis, we have characterized the cDNA for a human glutamate receptor subunit gene ¶ and determined its chromosomal localization.
MATERIALS AND METHODS
Isolation of Human cDNAs. Poly(A)+ RNA was isolated from the brains of Wistar rats. One microgram of rat brain poly(A)+ RNA was transcribed with avian myeloblastosis virus reverse transcriptase. A pair of 34-residue oligonucleotides with a 10-nucleotide (nt) Xho I site on a 5' end were synthesized:
The last 24 nucleotides of KA1 correspond to nucleotides 400-424 and the last 24 nucleotides of KA2 correspond to the complement of nucleotides 894-918 of the published sequence of GluRI (5). The oligonucleotides KA1 and KA2 were used as primers in a polymerase chain reaction (PCR) with the rat brain cDNA. This PCR product was gel purified and random primed (10) . About 400,000 recombinants of a human brainstem-cerebellum AGT11 cDNA library (11) were screened with this radiolabeled probe under reduced strin- (12, 13) . Amino acid alignments were performed with the CLUSTAL program, utilizing gaps of up to 10 amino acids and a gap penalty of 10 (14) . A phylogenetic comparison was performed with the PAUP program (15) .
Genomic Blotting. Genomic blots of human DNA cleaved with the restriction enzymes BamHI, EcoRI, HindIll, and Xba I were prepared as described (16) . A genomic blot utilizing field inversion electrophoresis on human genomic DNA cleaved with Sfi I and Sal I was generously provided by Kai Wang. All blots were hybridized at high stringency (50%o formamide/4x SSPE at 420C) and washed to a final stringency of 0.2x SSPE at 600C.
RNA Blots and Ribonuclease Protection Assays. Northern blots were performed with S gg of poly(A)+ RNA isolated from postmortem human brain and hybridized and washed under the conditions described above for genomic blots. Ribonuclease protection assays (17) were performed with 5 ,ug of total RNA, and protected fragments were electrophoresed on denaturing 5% polyacrylamide gels and examined by autoradiography. The antisense cRNA probe used to detect mRNA for the human glutamate receptor GluHI was derived from a 500-base-pair (bp) Pst I-EcoRI fragment from the 5' end of GluHI cDNA cloned in pBluescript KS+ (Stratagene). The antisense cRNA control was derived from a 300-bp fragment of mouse ,B-actin. Both probes were hybridized in the same reaction and digested, and they gave protected fragments of 475 bp for the GluHI cRNA and multiple bands including the 220-bp one for the f-actin probe. Isolation of Human Genomic Clones. Two genome equivalents of a human cosmid library were screened with randomprimed probe at high stringency by colony hybridization.
Chromosomal Preparation. Prometaphase chromosomes were prepared from peripheral blood lymphocytes by using the bromodeoxyuridine synchronization method (18) .
In Situ Hybridization. Cosmid DNAs were labeled with biotin-11-dUTP (Sigma) by using nick translation. Preannealing the probe and in situ hybridization were performed as described by Lichter et al. (19) with some modification.
To generate clear reverse bands (20), chromosome preparations were then counterstained with chromomycin A3 followed by distamycin (J.K., unpublished method), a modification of the procedure of Magenis et al. (21) . To simultaneously see both the fluorescein isothiocyanate (FITC) signal and the banding pattern, Zeiss filter set 05 was utilized and the resulting image was photographed with Kodak technical pan film.
RESULTS
Isolation and Characterization of the Human KA Receptor cDNA. To isolate a human glutamate receptor cDNA, we screened, under reduced stringency conditions, a human brain cDNA library with a rodent probe. The probe was derived by PCR amplification of reverse-transcribed rat brain RNA by using oligonucleotide primers based on the sequence of the rat KA/AMPA-sensitive receptor GluRI. This screen yielded eight positive A clones. One clone, designated GluHI, contained a 3.1-kilobase (kb) insert, and the sequence of this clone was determined by chain termination methods on both strands. The predicted protein encoded by the GluHI cDNA is 907 amino acids ( Fig. 1 ) with molecular weight of 100,000. The predicted amino acid sequence of GluHI has 97% identity with the rodent GluRI (3). There is a potential signal peptide after the first ATG of the longest open reading frame.
GluHI Identifies a Widely Expressed mRNA. KA receptors have been shown to be widely expressed in rodent brain (4) . GluHI identified a single 5.5-kb message on RNA blots of poly(A)+ RNA isolated from human brainstem and cerebellum ( Fig. 2A) . Ribonuclease protection assays on total RNA indicate that GluHI is widely expressed in human brain. The relative order of abundance of message identified by GluHI antisense cRNA is cerebellum > temporal cortex -frontal cortex = hypothalamus > spinal cord (Fig. 2B) . The GluHI message is not identified in human muscle (Fig. 2B, Fig. 4 (22) . The deduced amino acid sequences are from GluRI (3), GluR-K2 (5), GluRC, GluRD (4), and GluR5 (7) .
suggests that the respective mRNAs are unlikely to be ligand (25) . (Fig. 4) of the human and rodent glutamate receptors are shown above the identical regions of KA receptors and chicken (23) and frog (24) KA-binding GluHI in Fig. 1 . These same regions are predicted to be proteins suggests that these genes arose from multiple dumembrane-spanning a-helices by Nakanishi et al. (5) (26) . While the location also expect that this diversity will be generated by a similar of these membrane-spanning regions cannot be predicted family of genes.
with certainty (27) , the evolutionary conservation in amino
The proposed structure of ligand-gated channels is based acid sequence in this region among different subunits and on four or more membrane-spanning a-helices and an extrabetween species suggests a strong selection against nonsyncellular amino-terminal region that would interact with the onymous substitutions.
Proc. Natl. Acad. Sci. USA 88 (1991) Many of the amino acid differences (9 of 25 amino acids) between GluHI and GluRI are in a single 38-amino acid region defined by Sommer et al. (22) . This region separates the third and fourth predicted membrane-spanning regions (Tm3 and Tm4) and is strongly conserved in KA receptors, but it shows considerable divergence in other ionotropic receptors. In rodent KA receptors this region is encoded by alternatively spliced exons. The amino acids encoded by this exon in rodent KA/AMPA receptors are indicated above the same region ofGluHI in Fig. 1 4 . Phylogram comparing the degree of relatedness in amino acid sequence between human GluHI, the rodent KA receptor subunits, and chicken and frog KA-binding proteins (KBP). The rodent sequences used for this comparison are those utilized and cited in Fig. 1 . The other deduced amino acid sequences are from chicken KBP (23) and frog KBP (24) . The degree of identity and similarity between GluHI and the other kainate cDNAs is indicated in numbers below representing percent identity/percent similarity as determined by a FASTA comparison (13) . mer et al. (22) have designated these different types of receptor subunits "flip" and "flop." The human cDNA encoding GluHI would be considered as the flip counterpart to the flop version of the rodent clone GluRI (5). The conservation of the sequences encoding the flip type of receptor in GluHI suggests that the alternative splicing of similar exons will be used in human glutamate receptor genes.
The gene encoding this subunit of the KA receptors is localized to the q33 region of human chromosome 5 (Fig. 3) . Two other receptor genes have been mapped to this band. They include the colony-stimulating factor 1 receptor (CSF1R) and platelet-derived growth factor (3 receptor (PDG-FRB). These two receptors are within 0.5 kb of each other and are believed to have arisen by a duplication event, since they are significantly similar (28) . The human y-taminobutyric acid receptor A subunit (GABAA-R) has also been mapped to 5q34-35 by in situ hybridization (29) . Although these genes all encode cell surface receptors, they do not share any obvious similarity to GluHI at the amino acid level. Nevertheless, it is certainly possible that the PDGFRB, CSF1R, and GluHI genes are clustered in this region of human chromosome 5. However, the assignment of both CSF1R and PDGFRB to 5q33 is less precise than the present assignment because of the lower resolution ofthe techniques used to map them. Therefore, the GluHI gene may not be as close as currently indicated to the CSF1R and PDGFRB genes.
Although human chromosome 5 is composed of regions homologous to five mouse (Mus musculus) chromosomes, band 5q33 falls in a small region of overlap between homologous regions that are located on chromosomes 11 (MMU11) and 18 (MMU18) (30, 31) . It is of interest that five neurogenetic mutations in the mouse have been mapped to a 5-centimorgan region located in the homologous region on MMU11 (32) . These include shaker-2 (sh-2) (33) , spasmodic (spd) (34), vibrator (vb) (35) , tipsy (ti) (36) , and trembler (Tr) (37) . It would therefore be of interest to use the human cosmids KAG1.1, KAG2.1, and KAG3.1 to map the gene encoding the mouse counterpart of this subunit and determine its segregation with these mouse mutations. The vb mutant is especially interesting because the expression of this specific glutamate receptor subunit is highest in the cerebellum, one of the areas affected in the spinocerebellar degeneration seen 7560 Neurobiology: Puckett et al.
in vb mutants (35) . Although the precise region of homology is less well mapped on MMUY18, we note a further five mutations on this chromosome that may be of interest when map positions of the homologous region are defined (32) .
While it has not been shown that excitoxicity is involved in any human neurological disorder, this concept remains an attractive hypothesis in explaining disorders characterized by neuronal degeneration (9) . However, there are no inherited human neurological disorders known to map near the GluHI gene at 5q33. The closest genetically determined neurological disorder in humans are two forms of spinal muscular atrophy that map to the 5q11-13 region (38) . Linkage analysis has also shown an association between anonymous markers on Sq and schizophrenia in several Icelandic and British families (39) . This association was not seen in other pedigrees (40) . However, it would be interesting to see if the GluHI gene segregates with affected individuals in the British and Icelandic families. The molecular cloning of additional human glutamate receptor genes will be necessary to confirm the conservation of this gene family in humans. Determining the chromosomal location of each member of this gene family will establish whether the glutamate receptor genes map near any genes associated with neurogenetic disorders in mouse or man.
